Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (151-160 of 476) with videos related to

Pageof 48
Sort By:
Pathology International|June 28, 2003
Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervixHitoshi Tsuda, Yoshiki Mikami, Tsunehisa Kaku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 23, 2015
[A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Paclitaxel and Bevacizumab after Radical Mastectomy]Nanae Sakaguchi, Tomoyuki Moriya, Tamio Yamazaki, et al.
Cancer Research|August 3, 2007
Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancerRyoko Kikuchi, Hitoshi Tsuda, Yae Kanai, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Squamous cell carcinoma of the breast in the form of an intracystic tumorTakashi Shigekawa, Hitoshi Tsuda, Kazuhiko Sato, et al.
Breast Cancer (Tokyo, Japan)|September 2, 2015
Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary managementYuya Sato, Takayuki Kinoshita, Junko Suzuki, et al.
Japanese Journal of Clinical Oncology|May 30, 2009
Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancerChikako Shimizu, Norikazu Masuda, Kenichi Yoshimura, et al.
Acta Histochemica Et Cytochemica|April 11, 2015
High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian CancerReiko Iwadate, Jun Inoue, Hitoshi Tsuda, et al.
Japanese Journal of Clinical Oncology|March 15, 2015
Laminin β3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancerSatomi Fukazawa, Eiji Shinto, Hitoshi Tsuda, et al.
Pathology International|June 29, 2005
Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteriaHitoshi Tsuda, Yoshiki Mikami, Tsunehisa Kaku, et al.
Japanese Journal of Clinical Oncology|April 17, 2002
Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancersKazuaki Miyamoto, Takashi Fukutomi, Kiyoshi Asada, et al.
Pageof 48

Showing results (151-160 of 476) with videos related to

Sort By:
Pageof 48
Pathology International|June 28, 2003
Interobserver variation in the diagnosis of adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervixHitoshi Tsuda, Yoshiki Mikami, Tsunehisa Kaku, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 23, 2015
[A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Paclitaxel and Bevacizumab after Radical Mastectomy]Nanae Sakaguchi, Tomoyuki Moriya, Tamio Yamazaki, et al.
Cancer Research|August 3, 2007
Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancerRyoko Kikuchi, Hitoshi Tsuda, Yae Kanai, et al.
Breast Cancer (Tokyo, Japan)|January 25, 2007
Squamous cell carcinoma of the breast in the form of an intracystic tumorTakashi Shigekawa, Hitoshi Tsuda, Kazuhiko Sato, et al.
Breast Cancer (Tokyo, Japan)|September 2, 2015
Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary managementYuya Sato, Takayuki Kinoshita, Junko Suzuki, et al.
Japanese Journal of Clinical Oncology|May 30, 2009
Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancerChikako Shimizu, Norikazu Masuda, Kenichi Yoshimura, et al.
Acta Histochemica Et Cytochemica|April 11, 2015
High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian CancerReiko Iwadate, Jun Inoue, Hitoshi Tsuda, et al.
Japanese Journal of Clinical Oncology|March 15, 2015
Laminin β3 expression as a prognostic factor and a predictive marker of chemoresistance in colorectal cancerSatomi Fukazawa, Eiji Shinto, Hitoshi Tsuda, et al.
Pathology International|June 29, 2005
Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteriaHitoshi Tsuda, Yoshiki Mikami, Tsunehisa Kaku, et al.
Japanese Journal of Clinical Oncology|April 17, 2002
Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancersKazuaki Miyamoto, Takashi Fukutomi, Kiyoshi Asada, et al.
Pageof 48